Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study (2015)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; PINTO, GELBA ALMEIDA - HU ; GUSUKUMA, MARIA CECILIA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Subjects: COLESTEROL; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Clinical and Experimental Medicine
- ISSN: 1940-5901
- Volume/Número/Paginação/Ano: v. 8, n. 4, p. 5978-5988, 2015
-
ABNT
ZAMBRANO, Tomás et al. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. International Journal of Clinical and Experimental Medicine, v. 8, n. 4, p. 5978-5988, 2015Tradução . . Disponível em: http://www.ijcem.com/files/ijcem0006450.pdf. Acesso em: 19 abr. 2024. -
APA
Zambrano, T., Hirata, M. H., Cerda, A., Dórea, E. L., Pinto, G. A., Gusukuma, M. C., et al. (2015). Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study. International Journal of Clinical and Experimental Medicine, 8( 4), 5978-5988. Recuperado de http://www.ijcem.com/files/ijcem0006450.pdf -
NLM
Zambrano T, Hirata MH, Cerda A, Dórea EL, Pinto GA, Gusukuma MC, Bertolami MC, Salazar LA, Hirata RDC. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study [Internet]. International Journal of Clinical and Experimental Medicine. 2015 ; 8( 4): 5978-5988.[citado 2024 abr. 19 ] Available from: http://www.ijcem.com/files/ijcem0006450.pdf -
Vancouver
Zambrano T, Hirata MH, Cerda A, Dórea EL, Pinto GA, Gusukuma MC, Bertolami MC, Salazar LA, Hirata RDC. Impact of 3’UTR genetic variants in PCSK9 and LDLR genes on plasma lipid traits and response to atorvastatin in Brazilian subjects: a pilot study [Internet]. International Journal of Clinical and Experimental Medicine. 2015 ; 8( 4): 5978-5988.[citado 2024 abr. 19 ] Available from: http://www.ijcem.com/files/ijcem0006450.pdf - Impact of cholesterol-lowering therapies on gene expression of adhesion molecules in mononuclear cells from hypercholesterolemic patients
- Expression of inflammatory response genes in peripheral blood mononuclear cells from type 2 diabetes individuals treated with simvastatin and ezetimibe
- Downregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
- Factors associated with statin-related muscular adverse events in adult dyslipidemic outpatients
- Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients
- Dowregulation of monocyte adhesion molecules by inhibition of synthesis and absorption of cholesterol
- Physician-pharmacist collaborative intervention in the drug therapy optimization in patients with type 2 diabetes
- Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
- Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients
- Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individuals
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
